Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Risk of T-cell malignancy after CAR T-cell therapy in children, adolescents, and young adults

3 May 2024

Abstract excerpt

Our global survey reveals no cases of insertional mutagenesis following CAR T-cells in pediatric patients challenging concerns of secondary malignancy risk in this population.This underscores the safety of CAR T-cell therapy in this population, but ongoing surveillance required.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CAR-T cell therapy research
Share to Viral Infectious Diseases and Gene Expression in Insects
Share to Virus-based gene therapy research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38701425
DOI: 10.1182/bloodadvances.2024013243

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Risk of T-cell malignancy after CAR T-cell therapy in children, adolescents, and young adultsPMID 38701425Read ↗

The Fate(s) of CAR T-Cell Therapy: Navigating the Risks of CAR+ T-Cell MalignancySemantic proximity Read ↗

T-cell lymphomas in recipients of CAR-T cells: assessing risks and causalitiesSemantic proximity Read ↗

Engineering strategies to safely drive CAR T-cells into the futureSemantic proximity Read ↗

The progress of CAR-T therapy in cancer and beyondSemantic proximity Read ↗

Current Non-Viral-Based Strategies to Manufacture CAR-T CellsSemantic proximity Read ↗

CAR T-cells profiling in carcinogenesis and tumorigenesis: An overview of CAR T-cells cancer therapySemantic proximity Read ↗

CAR-T Cell TherapySemantic proximity Read ↗

CAR T cell therapy: newer approaches to counter resistance and costSemantic proximity Read ↗

Non-viral chimeric antigen receptor (CAR) T cells going viralSemantic proximity Read ↗

COVID-19 in pediatric cancer: where are the brain tumors?Semantic proximity Read ↗

Efficacy and safety of universal (TCRKO) ARI-0001 CAR-T cells for the treatment of B-cell lymphomaSemantic proximity Read ↗

Reprogramming human T cell function and specificity with non-viral genome targetingSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.